Results 181 to 190 of about 191,162 (262)

Surface-Engineered Phytochemical Nanomedicines for Postmenopausal Osteoporosis: Skeletal Targeting, Imaging-Supported Evaluation, and Therapeutic Performance. [PDF]

Pharmaceutics
Gao H, Li S, Wu H, Wang W, Song J, Li J, Shan X, Zhang W.   +7 more
europepmc   +1 more source

A Cross-Tissue Multiomics Analysis Reveals the Protective Role of TGFBR3 in Postmenopausal Osteoporosis. [PDF]

Int J Genomics
Liu Y, Xie C, Yang K, Liu Z, Liu R, Hou X, Xing L, Gao J, Lian Q, Hu Y, Wang Y, Zhang L, Tian F.   +12 more
europepmc   +1 more source

Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis. [PDF]

Pharmacoecon Open
Flanigan J, Kane S, Mirzayeh Fashami F, Zhou A, Almuallem L, Tindal M, Schauf M, Li E, Lyman GH.   +8 more
europepmc   +1 more source

Neddylation of NFATc1 and Runx2 regulates osteoclast-osteoblast balance and represents a dual-action therapeutic target for postmenopausal osteoporosis. [PDF]

Exp Mol Med
Lee J, Lee MY, Kim HS, Park JW, Moon GH, Park JB, Kim HJ, Kim SJ, Chun YS.   +8 more
europepmc   +1 more source

Eldecalcitol and calcium supplementation in Chinese women with postmenopausal osteoporosis: a prospective observational cohort study. [PDF]

J Bone Miner Metab
Jiang Y, Zeng Y, Xin L, Chen W, Xu Y, Tian S, Wang Q, Li J, Chen S, Lin X, Ying Q, Chiba S, Yamagiwa C, Yamaguchi T, Ke Z, Xia W, Takeuchi Y.   +16 more
europepmc   +1 more source

Three-year longitudinal assessment of denosumab's efficacy and safety in postmenopausal osteoporosis: a 36-month real-world cohort study. [PDF]

Front Med (Lausanne)
Xia RL, Li C, Wang L, Chao AJ, Wei W.
europepmc   +1 more source

Bone-Targeted Therapies and Spinal Morphometry in Postmenopausal Osteoporosis: A Real-World Longitudinal Retrospective Study. [PDF]

Bioengineering (Basel)
Wu ZW, Chen SW, Li SH, Wu WT, Peng CH, Chen HW, Chang CM, Yu TC, Chen IH, Wang JH, Yeh KT.   +10 more
europepmc   +1 more source

Macrophage polarization regulates bone homeostasis: a potential etiology and therapy for postmenopausal osteoporosis. [PDF]

Front Immunol
Danzeng Q, Wu F, Cui M, Shen Y, Li Y, Jiao J, Jiang W.   +6 more
europepmc   +1 more source

A Comparison Between Bisphosphonates and Teriparatide in the Treatment of Postmenopausal Osteoporosis: A Systematic Review. [PDF]

Cureus
Mann RS, Chopra I, Kilic A, Saxena A, Khan B, Rupanshu R, Chavez Cavalie PS.   +6 more
europepmc   +1 more source